Physician
Ahs Oklahoma Physician Group LLC
Ahs Oklahoma Physician Group LLC was paid $17.43M by Medicaid between Jan 2018 and Dec 2024, across 164 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoAHS OKLAHOMA PHYSICIAN GROUP LLC
TULSA, OK 74104
TULSA, OK 74104
33aNPI1235182775assigned 05/18/2006
33bProvider typeOtolaryngology Physician
28Total paid$17.43M
24GClaims344,323
24DCodes billed164
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Otolaryngology Physician providers in Oklahoma
Rank by total paid#1 of 19
Median peer was paid$55K
This provider vs. median316×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,842 | $2.43M | |
| 2019 | 43,385 | $2.18M | |
| 2020 | 36,204 | $1.68M | |
| 2021 | 45,197 | $2.31M | |
| 2022 | 54,612 | $2.95M | |
| 2023 | 56,525 | $3.20M | |
| 2024incomplete | 59,558 | $2.66M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 83,141 | 77,555 | $5.04M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 63,890 | 59,953 | $4.37M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.2% | 12,378 | 11,942 | $1.08M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.3% | 9,955 | 9,952 | $918K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.9% | 12,452 | 12,314 | $511K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.8% | 5,277 | 5,275 | $483K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.7% | 4,170 | 4,168 | $466K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.4% | 6,636 | 3,010 | $417K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 2.0% | 219 | 219 | $350K |
| 99222 | Initial hospital care, per day, moderate complexity | 1.8% | 3,451 | 3,393 | $312K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.5% | 16,910 | 16,795 | $264K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.4% | 3,266 | 3,266 | $247K |
152 more codes
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.3% | 8,900 | $230K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.3% | 1,514 | $226K |
| 99232 | Hospital visit by a doctor, follow-up day | 1.3% | 4,915 | $220K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.2% | 2,021 | $202K |
| 99223 | Prolong inpt eval add15 m | 1.0% | 1,374 | $175K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,608 | $119K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,823 | $118K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 4,005 | $117K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 294 | $111K |
| 99284 | Emergency room visit (serious) | <1% | 1,102 | $110K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,635 | $96K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,250 | $89K |
| 87428 | <1% | 1,512 | $78K | |
| 95819 | <1% | 295 | $63K | |
| 95886 | <1% | 696 | $62K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,732 | $46K |
| 99381 | <1% | 437 | $42K | |
| 97597 | <1% | 2,327 | $41K | |
| 43235 | <1% | 653 | $40K | |
| 92557 | <1% | 1,331 | $37K | |
| 99285 | Emergency room visit (most serious) | <1% | 244 | $37K |
| 73630 | <1% | 1,451 | $32K | |
| 76801 | <1% | 325 | $32K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 278 | $31K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,070 | $28K |
| 90474 | <1% | 1,865 | $28K | |
| 95720 | <1% | 198 | $27K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 332 | $26K |
| 99221 | <1% | 397 | $25K | |
| 87400 | <1% | 1,155 | $25K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 471 | $24K |
| 95913 | <1% | 137 | $24K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 339 | $23K |
| 81025 | <1% | 3,145 | $23K | |
| 92587 | <1% | 1,211 | $22K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 66 | $16K |
| 92567 | <1% | 1,129 | $15K | |
| 92579 | <1% | 391 | $15K | |
| 92588 | <1% | 602 | $15K | |
| 64615 | <1% | 203 | $14K | |
| 72110 | <1% | 494 | $13K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,607 | $13K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 66 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 974 | $12K |
| 92552 | <1% | 410 | $11K | |
| 90686 | <1% | 4,787 | $11K | |
| 92550 | <1% | 757 | $11K | |
| 92555 | <1% | 498 | $11K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 139 | $10K |
| 59426 | <1% | 13 | $9K | |
| 99205 | Prolong outpt/office vis | <1% | 62 | $9K |
| 99442 | <1% | 102 | $8K | |
| 11045 | <1% | 124 | $8K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 56 | $7K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 146 | $7K |
| 87807 | <1% | 630 | $7K | |
| 52000 | <1% | 84 | $7K | |
| 99460 | <1% | 80 | $7K | |
| 90715 | <1% | 368 | $7K | |
| 99441 | <1% | 133 | $6K | |
| 73610 | <1% | 218 | $5K | |
| 99307 | <1% | 381 | $3K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 30 | $3K |
| 62323 | <1% | 58 | $3K | |
| 64483 | <1% | 42 | $3K | |
| 20610 | <1% | 81 | $3K | |
| 72050 | <1% | 86 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 24 | $2K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 67 | $2K |
| 0001A | <1% | 66 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 294 | $2K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 615 | $2K |
| 72100 | <1% | 92 | $2K | |
| 85027 | <1% | 347 | $2K | |
| 0071A | <1% | 62 | $2K | |
| 0002A | <1% | 46 | $2K | |
| 90661 | <1% | 113 | $2K | |
| 93040 | <1% | 191 | $2K | |
| 0072A | <1% | 48 | $2K | |
| 99283 | Emergency room visit (moderate) | <1% | 33 | $2K |
| 90656 | <1% | 306 | $2K | |
| 11043 | <1% | 16 | $1K | |
| 94729 | <1% | 206 | $1K | |
| 94726 | <1% | 151 | $1K | |
| 90473 | <1% | 88 | $1K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 12 | $1K |
| 64642 | <1% | 12 | $1K | |
| 83655 | <1% | 99 | $1K | |
| 90677 | <1% | 414 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 18 | $1K |
| 51798 | <1% | 262 | $995.60 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 106 | $975.62 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 14 | $972.00 |
| 94060 | <1% | 139 | $967.50 | |
| 72040 | <1% | 51 | $959.51 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 101 | $909.08 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 85 | $760.05 |
| 0081A | <1% | 18 | $680.01 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 60 | $547.25 |
| 73030 | <1% | 42 | $538.72 | |
| 90681 | <1% | 719 | $516.80 | |
| 91200 | <1% | 26 | $490.49 | |
| 73130 | <1% | 26 | $453.92 | |
| 73564 | <1% | 26 | $453.43 | |
| 90651 | <1% | 426 | $446.72 | |
| 85018 | <1% | 196 | $433.02 | |
| 73502 | <1% | 30 | $430.22 | |
| 87070 | <1% | 46 | $389.31 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 115 | $341.62 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 39 | $334.04 |
| 96127 | <1% | 85 | $298.97 | |
| 95816 | <1% | 19 | $271.54 | |
| 73110 | <1% | 13 | $270.58 | |
| 90670 | <1% | 4,696 | $211.52 | |
| 90660 | <1% | 16 | $162.18 | |
| 11721 | <1% | 12 | $146.98 | |
| 90619 | <1% | 56 | $145.46 | |
| 88720 | <1% | 29 | $125.16 | |
| 99497 | <1% | 14 | $92.68 | |
| 51741 | <1% | 25 | $90.95 | |
| 99152 | <1% | 12 | $83.76 | |
| 87210 | <1% | 13 | $64.09 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 72 | $34.07 |
| 81001 | <1% | 13 | $33.84 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 75 | $28.67 |
| 90697 | <1% | 574 | $0.01 | |
| 90734 | 0% | 237 | $0.00 | |
| 90710 | 0% | 299 | $0.00 | |
| 90648 | 0% | 1,714 | $0.00 | |
| 90633 | 0% | 1,375 | $0.00 | |
| 90700 | 0% | 215 | $0.00 | |
| 3078F | 0% | 2,936 | $0.00 | |
| 90707 | 0% | 198 | $0.00 | |
| 90671 | 0% | 12 | $0.00 | |
| 90672 | 0% | 87 | $0.00 | |
| 91300 | 0% | 57 | $0.00 | |
| 91308 | 0% | 30 | $0.00 | |
| 90680 | 0% | 1,266 | $0.00 | |
| 3074F | 0% | 4,082 | $0.00 | |
| 90698 | 0% | 665 | $0.00 | |
| 3008F | 0% | 6,132 | $0.00 | |
| 90696 | 0% | 185 | $0.00 | |
| 90716 | 0% | 211 | $0.00 | |
| 90723 | 0% | 2,170 | $0.00 | |
| 3079F | 0% | 586 | $0.00 | |
| 3044F | 0% | 262 | $0.00 | |
| 90647 | 0% | 1,148 | $0.00 | |
| 3075F | 0% | 68 | $0.00 | |
| 90744 | 0% | 144 | $0.00 | |
| 91307 | 0% | 41 | $0.00 | |
| 90620 | 0% | 13 | $0.00 | |
| 3080F | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMUDD, BRANDON (CHIEF FINANCIAL OFFICER)
Parent organizationAHS OKLAHOMA PHYSICIAN GROUP, LLC